Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KOSDAQ - Delayed Quote KRW

DIO Corporation (039840.KQ)

Compare
16,890.00
-30.00
(-0.18%)
At close: April 4 at 3:30:30 PM GMT+9
Loading Chart for 039840.KQ
  • Previous Close 16,920.00
  • Open 17,010.00
  • Bid 16,560.00 x --
  • Ask 16,880.00 x --
  • Day's Range 16,510.00 - 17,010.00
  • 52 Week Range 15,130.00 - 22,750.00
  • Volume 37,302
  • Avg. Volume 32,902
  • Market Cap (intraday) 235.207B
  • Beta (5Y Monthly) 0.68
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 14, 2025 - May 19, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 21,666.67

DIO Corporation manufactures and sells dental implants in South Korea and internationally. The company offers UFII implant internal submerged and no-submerged systems, FTN implant external systems, protem implants, and UV active implant systems. It also provides digital dental implant solutions; and dental products and cardiovascular medical devices. The company was formerly known as DSI Co., Ltd and changed its name to DIO Corporation in August 2008. DIO Corporation was founded in 1988 and is headquartered in Busan, South Korea.

www.dio.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 039840.KQ

View More

Performance Overview: 039840.KQ

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

039840.KQ
4.65%
KOSPI Composite Index (^KS11)
2.75%

1-Year Return

039840.KQ
23.92%
KOSPI Composite Index (^KS11)
10.09%

3-Year Return

039840.KQ
52.62%
KOSPI Composite Index (^KS11)
10.61%

5-Year Return

039840.KQ
29.03%
KOSPI Composite Index (^KS11)
42.89%

Compare To: 039840.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 039840.KQ

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    235.21B

  • Enterprise Value

    265.23B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.04

  • Price/Book (mrq)

    1.15

  • Enterprise Value/Revenue

    2.22

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -34.53%

  • Return on Assets (ttm)

    -8.78%

  • Return on Equity (ttm)

    -20.74%

  • Revenue (ttm)

    119.65B

  • Net Income Avi to Common (ttm)

    -41.32B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    54.86B

  • Total Debt/Equity (mrq)

    41.59%

  • Levered Free Cash Flow (ttm)

    23.14B

Research Analysis: 039840.KQ

View More

Company Insights: 039840.KQ

Research Reports: 039840.KQ

View More

People Also Watch